References
- 1. JHA V, GARCIA-GARCIA G, ISEKI K, LI Z, NAICKER S, PLATTNER B, et al. Chronic kidney disease: global dimension and perspectives. The Lancet. 2013;382(9888):260–72.
- 2. CLARKSON KA, ROBINSON K. Life on dialysis: a lived experience. Nephrol Nurs J. 2010;37(1):29–35.
- 3. CHUASUWAN A, POORIPUSSARAKUL S, THAKKINSTIAN A, INGSATHIT A, PATTANAPRATEEP O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual. life outcomes. 2020;18(1):1–11.
- 4. MOUSAVI SSB, SOLEIMANI A, MOUSAVI MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi J Kidney Dis Transpl. 2014;25(3):697–702.
- 5. BELADI-MOUSAVI SS, ALEMZADEH-ANSARI MJ, ALEMZADEH-ANSARI MH, BELADI-MOUSAVI M. Long-term survival of patients with end-stage renal disease on maintenance hemodialysis: a multicenter study in Iran. Iran J Kidney Dis. 2012;6(6):452–56.
- 6. COZZOLINO M, MANGANO M, STUCCHI A, CICERI P, CONTE F, GALASSI A. Cardiovascular disease in dialysis patients. Nephrol. Dial. Transplant. 2018;33(suppl_3): iii28–iii34.
- 7. COUSER WG, REMUZZI G, MENDIS S, TONELLI M. The contribution of chronic kidney disease to the global burden of major no communicable diseases. Kidney Int. 2011;80(12):1258–70.
- 8. OSSAREH S, FARROKHI F, ZEBARJADI M. Survival of Patients on Hemodialysis and Predictors of Mortality: a Single-Centre Analysis of Time-Dependent Factors. Iran J Kidney Dis. 2016;10(6):369–80.
- 9. SOLTANI Z, RASHEED K, KAPUSTA DR, REISIN E. Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Curr. Hypertens. Rep. 2013;15(3):175–81.
- 10. LATIF W, KARABOYAS A, TONG L, WINCHESTER JF, ARRINGTON CJ, PISONI RL, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol. 2011;6(10):2470–77.
- 11. KIM CS, JIN D-C, YUN YC, BAE EH, MA SK, KIM SW. Relationship between serum uric acid and mortality among hemodialysis patients: Retrospective analysis of Korean end-stage renal disease registry data. Kidney Res Clin Pract. 2017;36(4):368–76.
- 12. PARK C, OBI Y, STREJA E, RHEE CM, CATABAY CJ, VAZIRI ND, et al. Serum uric acid, protein intake and mortality in hemodialysis patients. Nephrol Dial Transplant. 2017;32(10):1750–57.
- 13. BEBERASHVILI I, ERLICH A, AZAR A, SINUANI I, FELDMAN L, GORELIK O, et al. Longitudinal study of serum uric acid, nutritional status, and mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2016;11(6):1015–23.
- 14. LOVRE D, SHAH S, SIHOTA A, FONSECA VA. Managing diabetes and cardiovascular risk in chronic kidney disease patients. Endocrinol Metab Clin. 2018;47(1):237–57.
- 15. MURRAY T, GOLDBERG M. Chronic interstitial nephritis: etiologic factors. Ann Intern Med. 1975;82(4):453–55.
- 16. BEBERASHVILI I, SINUANI I, AZAR A, SHAPIRO G, FELDMAN L, STAV K, et al. Serum uric acid as a clinically useful nutritional marker and predictor of outcome in maintenance hemodialysis patients. Nutr J. 2015;31(1):138–47.
- 17. FIRTH D. Bias Reduction of Maximum Likelihood Estimates. Biometrika 1993; 80(1):27–38.
- 18. HEINZE G, PLONER M, DUNKLER D, SOUTHWORTH H, HEINZE MG. “Package ‘logistf” (2020).
- 19. KUCIRKA LM, GRAMS ME, LESSLER J, HALL EC, JAMES N, MASSIE AB, et al. Association of race and age with survival among patients undergoing dialysis. JAMA. 2011;306(6):620–26.
- 20. CHANDRASHEKAR A, RAMAKRISHNAN S, RANGARAJAN D. Survival analysis of patients on maintenance hemodialysis. Indian J Nephrol. 2014;24(4):206–13.
- 21. ECKARDT K-U, KIM J, KRONENBERG F, ALJAMA P, ANKER SD, CANAUD B, et al. Hemoglobin variability does not predict mortality in European hemodialysis patients. J Am Soc Nephrol. 2010;21(10):1765–75.
- 22. GOODKIN DA, FULLER DS, ROBINSON BM, COMBE C, FLUCK R, MENDELSSOHN D, et al. Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients. J Am Soc Nephrol. 2011;22(2):358–65.
- 23. KREDIET RT, BALAFA O. Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol. 2010;6(8):451–60.
- 24. CHANG TI, STREJA E, SOOHOO M, KIM TW, RHEE CM, KOVESDY CP, et al. Association of serum triglyceride to HDL cholesterol ratio with all-cause and cardiovascular mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2017;12(4):591–602.
- 25. RAJU D, LALITHA D, KIRANMAYI P. A study of lipid profile and lipid peroxidation in chronic kidney disease with special reference to hemodialysis. J Clinic Res Bioeth. 2013;4(1):1–5.
- 26. MIKOLASEVIC I, ŽUTELIJA M, MAVRINAC V, ORLIC L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc dis. 2017; 10:35–45.
- 27. ZHANG B, GAO C, YANG N, ZHANG W, SONG X, YIN J, et al. Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke? BMC Neurol. 2010;10(1):1–6.
- 28. CHIQUETE E, RUIZ-SANDOVAL JL, MURILLO-BONILLA LM, ARAUZ A, OROZCO-VALERA DR, OCHOA-GUZMÁN A, et al. Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis. 2013;35(2):168–74.